• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  09/26/2019
Trade Name:  Mavyret
Generic Name or Proper Name (*):  glecaprevir and pibrentasvir
Indications Studied:  Chronic hepatitis C virus infection (HCV) 12 years and older or weighing at least 45 kg
Label Changes Summary:  *The treatment duration for chronic HCV for treatment-naïve patients was changed from 12 weeks to 8 weeks. *The new 8-week treatment duration for genotypes (GTs) 1,2,3,4,5 and 6 for treatment-naïve patients with compensated cirrhosis with Chronic Hepatitis C Virus (HCV) infection is supported by the EXPEDITION-8 study. *Information on dosing, and clinical trial. *New dosing regimen. *Postmarketing study.
Sponsor:  AbbVie Inc.
Therapeutic Category:  Antiviral